HEGNSEHEG Limited· Industrial ProductsHighNeutral
Announced Tue, 10 Feb, 2026 · 19:05 IST

HEG Q3 PAT up 44% at Rs 141 cr, revenue up 37% YoY; multiple corporate actions

Revenue Growth 20pctPat Growth 25pctEmphasis Of MatterResults View source PDFExplain this filing

HEG · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-5.6%Reaction day
₹557.50
prior close
₹594.00
announcement price
After-mkt
timing
Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.1%-5.7% vs market
Electrodes & Refractories peers, median of 10sector-1.3%-4.3% vs sector

On the reaction day the stock moved 5.7 pts less than Nifty Smallcap 250 and 4.3 pts less than its Electrodes & Refractories peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-3.6
10m
-4.7
15m
-5.5
30m
-9.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-5.6+0.1-5.7-1.3-4.3
Next day
-4.8-0.6-4.1-1.8-3.0
2d
-5.8-2.2-3.6-4.5-1.3
3d
-4.7-2.3-2.5-5.6+0.9
4d
-6.0-1.5-4.4-5.2-0.8
5d
-0.9-1.0+0.1-5.2+4.3
1w
+0.3-2.4+2.6-8.1+8.4
15d
-2.8-5.4+2.6-12.8+10.0
1m
-5.8-6.3+0.5-12.1+6.4
2m
+1.3-4.0+5.4-9.7+11.1
3m
+5.9+5.5+0.4-4.9+10.8
UpDownMarket · Nifty Smallcap 250Sector · Electrodes & Refractories peers, median of 10Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

HEG Limited posted strong Q3 FY26 results. Standalone revenue grew 37% to Rs 655.66 cr, while PAT rose 44% to Rs 141.25 cr. For 9M FY26, revenue grew 22% to Rs 1,965 cr and PAT more than doubled to Rs 344 cr. Consolidated Q3 PAT was Rs 206 cr. Board also approved a Rs 1,230 cr corporate guarantee for wholly owned subsidiary TACC, Rs 400 cr OCD subscription in TACC, winding up the small medical transcription unit of another subsidiary, and transfer of a 51% hydro power stake. Auditor flagged an emphasis of matter on associate BEL's hydro power subsidiaries.

Likely market impact

Strong earnings beat with 22% revenue and over 100% PAT growth in 9M; corporate actions expand subsidiary support but add contingent liabilities.